Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 11, 2011, Pages 2384-2395

  Friedenreich, Christine M ^a,b   Biel, Rita K ^a   Lau, David C W ^c   Csizmadi, Ilona ^a,b   Courneya, Kerry S ^d   Magliocco, Anthony M ^b   Yasui, Yutaka ^d   Cook, Linda S ^a,b,e  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD ANALYSIS; BODY MASS; CANADA; CANCER RISK; CASE CONTROL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; METABOLIC SYNDROME X; PHOTOMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 81155126119     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0715     Document Type: Article

References (61)

1. Canadian cancer statistics 2010. Toronto, Canada: Canadian Cancer Society; 2010.
2. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43. (Pubitemid 36020003)
3. Brand A, Dubuc-Lissoir J, Ehlen T, Plante M. SOGC clinical practice guidelines. Diagnosis of endometrial cancer in women with abnormal vaginal bleeding. J Soc Obstet Gynaecol Can 2000;22:102-4.
4. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
5. Shields M, Connor Grober S, Tremblay M. Estimates of obesity based on self-report versus direct measures. Health Reports Statistics Canada 2008;Catalogue no. 82-003-X.
6. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-92. (Pubitemid 30088399)
7. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2001;10:611-6. (Pubitemid 32705512)
8. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La VC. Hypertension and hormone-related neoplasms in women. Hypertension 1999;34:320-5. (Pubitemid 29409235)
9. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-54. (Pubitemid 32631468)
10. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation 2002;106:3143-421.
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
12. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
13. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-92. (Pubitemid 30088399)
14. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003;104:669-76. (Pubitemid 36418502)
15. Zhang Y, Liu Z, Yu X, Zhang X, Lu S, Chen X, et al. The association between metabolic abnormality and endometrial cancer: a large casecontrol study in China. Gynecol Oncol 2010;117:41-6.
16. Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010;171:892-902.
17. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjonneland A, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007;14:755-67. (Pubitemid 350074064)
18. Rosato V, Zucchetto A, Bosetti C, Maso LD, Montella M, Pelucchi C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol 2010;22:884-9.
19. Shou HF, Ni J, Zhu T, Chen JH, Zhang X, Xu XX, et al. [Association between endometrial cancer and metabolic syndrome]. Zhonghua Fu Chan Ke Za Zhi 2010;45:128-31.
20. Friedenreich CM, Cook LS, Magliocco AM, Duggan MA, Courneya KS. Case-control study of lifetime total physical activity and endometrial cancer risk. Cancer Causes Control 2010;21:1105-16.
21. Waksberg J. Sampling methods for randomdigit dialing. JAmStat Soc 1978;73:40-6.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Hosmer DW LS. Applied logistic regression. New York, NY: Wiley; 1989.
24. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
25. Vainio H, Bianchini F. Weight control and physical activity. Lyon, France: IARC Handbooks for Cancer Prevention Vol 6. 2002.
26. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer 2009;124:2938-41.
27. Swanson CA, Potischman N, Barrett RJ, Berman ML,Mortel R, Twiggs LB, et al. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol Biomarkers Prev 1994;3:575-81. (Pubitemid 24314446)
28. Ardern CI, Katzmarzyk PT. Geographic and demographic variation in the prevalence of metabolic syndrome in Canada. Can J Diab 2007;31:34-46. (Pubitemid 46513433)
29. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004;33:333-50. (Pubitemid 38680633)
30. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293-7.
31. Hiatt RA, Fireman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 1986;39:861-70. (Pubitemid 17229983)
32. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis 1980;33:311-32.
33. Wallace RB, Rost C, Burmeister LF, Pomrehn PR. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst 1982;68:915-8. (Pubitemid 12040914)
34. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981;245:247-52. (Pubitemid 11210650)
35. Bjorge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 2007;120:378-83. (Pubitemid 44956850)
36. Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care 2010;33:2457-61.
37. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63:437S-41S. (Pubitemid 26075827)
38. La Vecchia C, Negri E, Franceschi S, Levi F. An epidemiological study of endometrial cancer, nutrition and health. Eur J Cancer Prev 1997;6:171-4. (Pubitemid 27296783)
39. Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer 1992;50:567-71.
40. Olson SH, Trevisan M, Marshall JR, Graham S, Zielezny M, Vena JE, et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 1995;23:141-9.
41. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004;96:1635-8. (Pubitemid 39534888)
42. Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998;148:234-40. (Pubitemid 28355341)
43. Shu XO, Brinton LA, Zheng W, Swanson CA, Hatch MC, Gao YT, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res 1992;52:3865-70.
44. Swanson CA, Potischman N, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993;2:321-7.
45. Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingleton HM. Endometrial cancer, obesity, and body fat distribution. Cancer Res 1991;51:568-72.
46. Iemura A, Douchi T, Yamamoto S, Yoshimitsu N, Nagata Y. Body fat distribution as a risk factor of endometrial cancer. J Obstet Gynaecol Res 2000;26:421-5. (Pubitemid 32043770)
47. Lapidus L, Helgesson O, Merck C, Bjorntorp P. Adipose tissue distribution and female carcinomas. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Int J Obes 1988;12:361-8.
48. Xu WH, Matthews CE, Xiang YB, Zheng W, Ruan ZX, Cheng JR, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 2005;161:939-47. (Pubitemid 40656416)
49. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, et al. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002;46:147-51. (Pubitemid 34920698)
50. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA 1991;266:1808-11.
51. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol 2011;121:376-82.
52. Jeong NH, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 2010;118:24-8.
53. Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer 2010;126:490-9.
54. Conroy MB, Sattelmair JR, Cook NR, Manson JE, Buring JE, Lee IM. Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control 2009;20:1107-15.
55. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008;98:1582-5. (Pubitemid 351652323)
56. McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 2008;17:73-9. (Pubitemid 351196275)
57. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
58. Friedenreich C, Cust A, LahmannPH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 2007;18:399-413. (Pubitemid 46434795)
59. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol 2006;35:151-8. (Pubitemid 43205462)
60. Xu WH, Xiang YB, Zheng W, Zhang X, Ruan ZX, Cheng JR, et al. Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 2006;35:159-66. (Pubitemid 43205463)
61. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077-85. (Pubitemid 27498123)